BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2014 3:13:00 PM | Browse: 1151 | Download: 1162
Publication Name World Journal of Gastroenterology
Manuscript ID 8493
Country Italy
Received
2013-12-29 14:40
Peer-Review Started
2013-12-29 15:32
To Make the First Decision
2014-02-26 15:29
Return for Revision
2014-03-13 18:47
Revised
2014-04-29 02:03
Second Decision
2014-07-16 12:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-16 13:04
Articles in Press
2014-07-16 17:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-08-05 05:34
Typeset the Manuscript
2014-10-27 15:12
Publish the Manuscript Online
2014-11-17 15:12
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
Manuscript Source Invited Manuscript
All Author List Giulia Paolella, Claudia Mandato, Luca Pierri, Marco Poeta, Martina Di Stasi and Pietro Vajro
Funding Agency and Grant Number
Funding Agency Grant Number
FARB-ex 60% 2012 of the University of Salerno (in part) to Vajro P
Corresponding Author Pietro Vajro, Professor, Chair of Pediatrics, Department of Medicine and Surgery, University of Salerno, via Allende, 84081 Baronissi (Salerno), Italy. pvajro@unisa.it
Key Words Probiotics; Gut-liver axis; Intestinal microbiota; Barrier function; Small intestinal bacterial overgrowth; Bacterial translocation; Non-alcoholic fatty liver disease
Core Tip Modulation of gut microbiota by probiotics is supported by a number of studies conducted with non-alcoholic fatty liver disease animal models and in several pilot pediatric and adult human studies. Globally, this approach appears to be a promising add-on therapeutic tool to be used in the context of a tailored multi-target therapy especially in cases where standard dietary and lifestyle changes have failed.
Publish Date 2014-11-17 15:12
Citation Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15518-15531
URL http://www.wjgnet.com/1007-9327/full/v20/i42/15518.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i42.15518
Full Article (PDF) WJG-20-15518.pdf
Full Article (Word) WJG-20-15518.doc
Manuscript File 8493-Review.docx
Answering Reviewers 8493-Answering reviewers.pdf
Copyright License Agreement 8493-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 8493-Language certificate.pdf
Peer-review Report 8493-Peer reviews.pdf
Scientific Misconduct Check 8493-CrossCheck.jpg
Scientific Editor Work List 8493-Scientific editor work list.pdf